Santhera Pharmaceuticals Holding AG (XSWX:SANN) EV-to-Revenue : 1.07 (As of Dec. 15, 2024)

Santhera Pharmaceuticals Holding AG EV-to-Revenue Chart

Santhera Pharmaceuticals Holding AG Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					2.06	7.30	-55.00	17.93	0.99

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-Revenue	Get a 7-Day Free Trial															-	17.93	-	0.99	-

Competitive Comparison of Santhera Pharmaceuticals Holding AG's EV-to-Revenue

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santhera Pharmaceuticals Holding AG's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's EV-to-Revenue falls into.

Santhera Pharmaceuticals Holding AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Santhera Pharmaceuticals Holding AG's EV-to-Revenue for today is calculated as:

Santhera Pharmaceuticals Holding AG's current Enterprise Value is CHF121.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Santhera Pharmaceuticals Holding AG's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was CHF113.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santhera Pharmaceuticals Holding AG  (XSWX:SANN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Santhera Pharmaceuticals Holding AG's PS Ratiofor today is calculated as:

Santhera Pharmaceuticals Holding AG's share price for today is CHF9.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was CHF10.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santhera Pharmaceuticals Holding AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Santhera Pharmaceuticals Holding AG Business Description